Find Ambrisentan manufacturers, exporters & distributors on PharmaCompass

Ambrisentan

DRL offers a portfolio of products & services, including APIs, CMO services, generics, biosimilars & differentiated formulations.

ACCESS ALL DATA
Browse all information
CHEMISTRY
Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

22 API Suppliers, 10 USDMF, 2 JDMF, 7 EU WC, 1 KDMF, 6 NDC API, 12 Listed Suppliers, $ API Reference Price

22 API Suppliers
10 USDMF
2 JDMF
7 EU WC
1 KDMF
6 NDC API
12 Listed Suppliers
$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

3 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers, 20 FDA Orange Book, 32 Europe, 8 Canada, 32 Australia, 4 South Africa, 6 Listed Dossiers

102 FDF Dossiers
20 FDA Orange Book
32 Europe
8 Canada
32 Australia
4 South Africa
6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma, 2 DKSH, 3 Faran Shimi Pharmaceutical, 9 Gangwal Healthcare, 3 Nanjing Well Pharmaceutical, 1 Aeon Procare, 4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 1 BASF, 5 Corel Pharma Chem, 5 DFE Pharma, 6 Gangwal Chemicals, 3 Ideal Cures Pvt Ltd, 1 Ingredion Pharma Solutions, 20 Kerry, 9 Microlex e.U, 1 Novo Excipients, 1 Pharmatrans-Sanaq, 3 Pluviaendo, 3 Prachin Chemical, 10 Roquette, 3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 11 Sigachi Industries, 3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders, 20 Coating Systems & Additives, 19 Direct Compression, 15 Disintegrants & Superdisintegrants, 13 Lubricants & Glidants, 11 Co-Processed Excipients, 10 Granulation, 10 Thickeners and Stabilizers, 9 Controlled & Modified Release, 5 Film Formers & Plasticizers, 4 Parenteral, 3 Taste Masking, 2 Coloring Agents, 2 Topical, 2 Rheology Modifiers, 2 Emulsifying Agents, 2 Chewable & Orodispersible Aids, 1 API Stability Enhancers, 1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow, 14 NEWS #PharmaBuzz

media
1 DATA COMPILATION #PharmaFlow
14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions, 26 Finished Drug Prices, 10 Annual Reports

globalSalesInformation
2 US Medicaid Prescriptions
26 Finished Drug Prices
10 Annual Reports

MARKET PLACE

6 APIs, 5 FDF Dossiers

marketPlace
6 APIs
5 FDF Dossiers

PATENTS & EXCLUSIVITIES

6 US Patents, 6 Health Canada Patents

patents
6 US Patents
6 Health Canada Patents

Synopsis

ACTIVE PHARMA INGREDIENTS

API Suppliers

USDMF

CEP/COS

JDMF

EU WC

KDMF

NDC API

VMF

Listed Suppliers

API REF. PRICE (USD/KG)

$ 41,719

MARKET PLACE

API

FDF

4INTERMEDIATES

FINISHED DOSAGE FORMULATIONS

102

FDF Dossiers

FDA Orange Book

Europe

Canada

Australia

South Africa

Listed Dossiers

3DRUGS IN DEVELOPMENT

DRUG PRODUCT COMPOSITIONS

REF. STANDARDS OR IMPURITIES

EDQM

USP

Others

PATENTS & EXCLUSIVITIES

US Patents

US Exclusivities

Health Canada Patents

DIGITAL CONTENT

Data Compilation #PharmaFlow

Stock Recap #PipelineProspector

Weekly News Recap #Phispers

News #PharmaBuzz

GLOBAL SALES INFORMATION

US Medicaid (USD)

350,219,632

Annual Reports (USD Million)

4,734

Finished Drug Prices

108 RELATED EXCIPIENT COMPANIES

172EXCIPIENTS BY APPLICATIONS

Chemistry

Click the arrow to open the dropdown

Click the button for full data set

Also known as: 177036-94-1, Letairis, Volibris, Lu-208075, Bsf 208075, Bsf-208075

Molecular Formula

C₂₂H₂₂N₂O₄

Molecular Weight

378.4 g/mol

InChI Key

OUJTZYPIHDYQMC-LJQANCHMSA-N

FDA UNII

HW6NV07QEC

Ambrisentan is an orally bioavailable, selective antagonist of the endothelin type-A (ETA) receptor that may be used for the treatment of pulmonary arterial hypertension (PAH). Upon administration, ambrisentan targets and binds to ETA receptor, which prevents the binding of endothelin-1 (ET-1) to the ETA receptor and ET-1/ETA-mediated vasoconstriction and cell proliferation. This may lead to vasodilation. ET-1 concentrations are increased in plasma as well as lung tissue in PAH, and ET-1 may play a key role in the pathogenesis of PAH.

Ambrisentan is an Endothelin Receptor Antagonist. The mechanism of action of ambrisentan is as an Endothelin Receptor Antagonist.

1 2D Structure

Ambrisentan

2 Identification

2.1 Computed Descriptors

2.1.1 IUPAC Name

(2S)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic acid

2.1.2 InChI

InChI=1S/C22H22N2O4/c1-15-14-16(2)24-21(23-15)28-19(20(25)26)22(27-3,17-10-6-4-7-11-17)18-12-8-5-9-13-18/h4-14,19H,1-3H3,(H,25,26)/t19-/m1/s1

2.1.3 InChI Key

OUJTZYPIHDYQMC-LJQANCHMSA-N

2.1.4 Canonical SMILES

CC1=CC(=NC(=N1)OC(C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C

2.1.5 Isomeric SMILES

CC1=CC(=NC(=N1)O[C@H](C(=O)O)C(C2=CC=CC=C2)(C3=CC=CC=C3)OC)C

2.2 Other Identifiers

2.2.1 UNII

HW6NV07QEC

2.3 Synonyms

2.3.1 MeSH Synonyms

1. (+)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

2. (+)-ambrisentan

3. (+-)-ambrisentan

4. (-)-ambrisentan

5. (r)-ambrisentan

6. (s)-ambrisentan

7. Ambrisentan, (+-)-

8. Ambrisentan, (-)-

9. Ambrisentan, (r)-

10. Bsf 208075

11. Bsf-208075

12. Bsf208075

13. Gsk 1325760

14. Gsk 1325760a

15. Gsk-1325760

16. Gsk-1325760a

17. Gsk1325760

18. Gsk1325760a

19. Letairis

20. Lu 208075

21. Lu-208075

22. Lu208075

23. Volibris

2.3.2 Depositor-Supplied Synonyms

1. 177036-94-1

2. Letairis

3. Volibris

4. Lu-208075

5. Bsf 208075

6. Bsf-208075

7. Lu 208075

8. (s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

9. (s)-2-(4,6-dimethylpyrimidin-2-yloxy)-3-methoxy-3,3-diphenylpropanoic Acid

10. (2s)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-diphenylpropanoic Acid

11. Gsk1325760a

12. Gsk-1325760a

13. Hw6nv07qec

14. Gsk1325760

15. Gsk-1325760

16. Chembl1111

17. Dsstox_cid_26282

18. Dsstox_rid_81508

19. Dsstox_gsid_46282

20. Ambrisentan [inn]

21. Lu208075

22. (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropanoic Acid

23. (s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy-3,3-diphenylpropionic Acid

24. Cas-177036-94-1

25. Unii-hw6nv07qec

26. Ambrisentan [inn:ban:jan]

27. Ncgc00160662-01

28. Letairis (tn)

29. Volibris (tn)

30. Ambrisentan- Bio-x

31. Ambrisentan (jan/inn)

32. Ambrisentan [mi]

33. Ambrisentan [jan]

34. Ambrisentan [vandf]

35. Schembl3679

36. Ambrisentan [mart.]

37. Ambrisentan [who-dd]

38. Ambrisentan, (+)-

39. Mls006010218

40. Ambrisentan [ema Epar]

41. Gtpl3951

42. Dtxsid4046282

43. Ambrisentan [orange Book]

44. Chebi:135949

45. Zinc538627

46. Ex-a3315

47. Tox21_111967

48. Bdbm50146710

49. Fd7219

50. Mfcd09842330

51. S2097

52. Akos015994540

53. Tox21_111967_1

54. Ac-9015

55. Ccg-268386

56. Cs-0447

57. Db06403

58. De-0223

59. (+)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

60. (+-)-(2s)-2-((4,6-dimethylpyrimidin-2-yl)oxy)-3-methoxy-3,3-diphenylpropanoic Acid

61. Ncgc00160662-02

62. Ncgc00346730-01

63. Ba164153

64. Benzenepropanoic Acid, Alpha-[(4,6-dimethyl-2-pyrimidinyl)oxy]-beta-methoxy-beta-phenyl-, (alphas)-

65. Hy-13209

66. Smr004701307

67. Sw219060-1

68. D07077

69. Ab01566890_01

70. Q410789

71. J-519579

72. (?s)-?-[(4,6-dimethyl-2-pyrimidinyl)oxy]-?-methoxy-?-phenylbenzenepropanoic Acid

73. (2s)-2-(4,6-dimethylpyrimidin-2-yl)oxy-3-methoxy-3,3-di(phenyl)propanoic Acid

74. (2s)-2-[(4,6-dimethylpyrimidin-2-yl)oxy]-3-methoxy- 3,3-diphenylpropanoic Acid

75. (s)-2-(4,6-dimethyl-pyrimidin-2-yloxy)-3-methoxy-3,3-diphenyl-propionic Acid

2.4 Create Date

2006-07-28

3 Chemical and Physical Properties

Molecular Formula	C₂₂H₂₂N₂O₄
Molecular Weight	378.4 g/mol
XLogP3	3.8
Hydrogen Bond Donor Count	1
Hydrogen Bond Acceptor Count	6
Rotatable Bond Count	7
Exact Mass	378.15795719 g/mol
Monoisotopic Mass	378.15795719 g/mol
Topological Polar Surface Area	81.5 Å²
Heavy Atom Count	28
Formal Charge	0
Complexity	475
Isotope Atom Count	0
Defined Atom Stereocenter Count	1
Undefined Atom Stereocenter Count	0
Defined Bond Stereocenter Count	0
Undefined Bond Stereocenter Count	0
Covalently Bonded Unit Count	1

4 Drug and Medication Information

4.1 Drug Indication

Ambrisentan is indicated for treatment of idiopathic (primary) pulmonary arterial hypertension (IPAH) and pulmonary arterial hypertension (PAH) associated with connective tissue disease in patients with WHO functional class II or III symptoms. In the United States of America, ambrisentan is also indicated in combination with tadalafil to reduce the risks of disease progression and hospitalization for worsening PAH, and to improve exercise ability.

FDA Label

Ambrisentan Mylan is indicated for the treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment. Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

Volibris is indicated for treatment of pulmonary arterial hypertension (PAH) in adult patients of WHO Functional Class (FC) II to III, including use in combination treatment (see section 5. 1). Efficacy has been shown in idiopathic PAH (IPAH) and in PAH associated with connective tissue disease.

Volibris is indicated for treatment of PAH in adolescents and children (aged 8 to less than 18 years) of WHO Functional Class (FC) II to III including use in combination treatment. Efficacy has been shown in IPAH, familial, corrected congenital and in PAH associated with connective tissue disease (see section 5. 1).

Pulmonary arterial hypertension

Treatment of pulmonary arterial hypertension

5 Pharmacology and Biochemistry

5.1 Pharmacology

Ambrisentan 10 mg daily had no significant effect on the QTc interval, whereas a 40 mg daily dose of ambrisentan increased mean QTc at tmax by 5 ms with an upper 95% confidence limit of 9 ms. Significant QTc prolongation is not expected in patients taking ambrisentan without concomitant metabolic inhibitors. Plasma concentrations of B-type natriuretic peptide (BNP) in patients who received ambrisentan for 12 weeks were significantly decreased. Two Phase III placebo-controlled studies demonstrated a decrease in BNP plasma concentrations by 29% in the 2.5 mg group, 30% in the 5 mg group, and 45% in the 10 mg group (p < 0.001 for each dose group) and an increase by 11% in the placebo group.

5.2 MeSH Pharmacological Classification

Antihypertensive Agents

Drugs used in the treatment of acute or chronic vascular HYPERTENSION regardless of pharmacological mechanism. Among the antihypertensive agents are DIURETICS; (especially DIURETICS, THIAZIDE); ADRENERGIC BETA-ANTAGONISTS; ADRENERGIC ALPHA-ANTAGONISTS; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; CALCIUM CHANNEL BLOCKERS; GANGLIONIC BLOCKERS; and VASODILATOR AGENTS. (See all compounds classified as Antihypertensive Agents.)

5.3 FDA Pharmacological Classification

5.3.1 Active Moiety

AMBRISENTAN

5.3.2 FDA UNII

HW6NV07QEC

5.3.3 Pharmacological Classes

Endothelin Receptor Antagonists [MoA]; Endothelin Receptor Antagonist [EPC]

5.4 ATC Code

C02KX02

S76 | LUXPHARMA | Pharmaceuticals Marketed in Luxembourg | Pharmaceuticals marketed in Luxembourg, as published by d'Gesondheetskeess (CNS, la caisse nationale de sante, www.cns.lu), mapped by name to structures using CompTox by R. Singh et al. (in prep.). List downloaded from https://cns.public.lu/en/legislations/textes-coordonnes/liste-med-comm.html. Dataset DOI:10.5281/zenodo.4587355

C - Cardiovascular system

C02 - Antihypertensives

C02K - Other antihypertensives

C02KX - Antihypertensives for pulmonary arterial hypertension

C02KX02 - Ambrisentan

5.5 Absorption, Distribution and Excretion

Absorption

Ambrisentan is rapidly absorbed with peak plasma concentrations occuring around 2 hours after oral administration. Cmax and AUC increase proportionally with dose across the therapeutic dosing range. Absolute oral bioavailability of ambrisentan is unknown. Absorption is not affected by food.

Route of Elimination

Ambrisentan is primarily cleared by non-renal pathways. Along with its metabolites, ambrisentan is primarily found in the feces following hepatic and/or extra-hepatic metabolism. Approximately 22% of the administered dose is recovered in the urine following oral administration with 3.3% being unchanged ambrisentan.

Volume of Distribution

Ambrisentan has a low distribution into red blow cells, with a mean blood:plasma ratio of 0.57 and 0.61 in males and females, respectively.

Clearance

The mean oral clearance of ambrisentan was found to be 38 mL/min in healthy subjects and 19 mL/min in patients with pulmonary artery hypertension.

5.6 Metabolism/Metabolites

Ambrisentan is a metabolized primarily by uridine 5-diphosphate glucuronosyltransferases (UGTs) 1A9S, 2B7S,1A3S to form ambrisentan glucuronide. Ambrisentan is also metabolized to a lesser extent by CYP3A4, CYP3A5 and CYP2C19 to form 4- hydroxymethyl ambrisentan which is further glucuronidated to 4-hydroxymethyl ambrisentan glucuronide.

5.7 Biological Half-Life

Ambrisentan has a terminal half-life of 15 hours. It is thought that steady state is achieved after around 4 days of repeat-dosing.

5.8 Mechanism of Action

Endothelin-1 (ET-1) is an endogenous peptide that acts on the endothelin type A (ETA) and endothelin type B (ETB) receptors in vascular smooth muscle and endothelium. ETA-mediated actions include vasoconstriction and cell proliferation, whereas ETB predominantly mediates vasodilation, anti-proliferation, and ET-1 clearance. In patients with pulmonary arterial hypertension, ET-1 levels are increased and correlate with increased right arterial pressure and severity of disease. Ambrisentan is one of several newly developed vasodilator drugs that selectively target the endothelin type A (ETA) receptor, inhibiting its action and preventing vasoconstriction. Selective inhibition of the ETA receptor prevents phospholipase C-mediated vasoconstriction and protein kinase C-mediated cell proliferation. Endothelin type B (ETB) receptor function is not significantly inhibited, and nitric oxide and prostacyclin production, cyclic GMP- and cyclic AMP-mediated vasodilation, and endothelin-1 (ET-1) clearance is preserved.

API SUPPLIERS

01

LGM Pharma

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

Contact Supplier

U.S.A

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF Others AUDIT

02

HRV Global Life Sciences

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Attending

HRV Global Life Sciences - Market Expansion Leader in Pharmaceuticals.

Contact Supplier

India

Virtual Booth

Digital Content

USDMF CEP/COS JDMF EU-WC NDC KDMF VMF AU

AUDIT

03

Medichem S.A

Spain

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Contact Supplier

Spain

Virtual Booth

Digital Content

USDMF

CEP/COS JDMF EU-WC NDC

KDMF VMF Others AUDIT

04

Sun Pharmaceutical Industries Limi...

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

05

Cipla

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

06

Zhejiang Huahai Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

07

Jiangsu Joyglory Pharmaceutical

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

08

Viatris

U.S.A

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

09

Tianjin Weijie Pharmaceutical Co.,...

China

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

10

Megafine Pharma (P) Limited

India

USDMF, CEP/COS, JDMF, EU-WC, NDC, KDMF, VMF, Others

CPHI Middle east

Not Confirmed

Only 10 entries up to this point, click to access all

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

USDMF

01

Medichem Manufacturing Malta Ltd

Spain

DDL Conference

Not Confirmed

Medichem is a vertically integrated pharmaceutical company specializing in the development & manufacturing of APIs & FDFs.

Contact Supplier

Spain

Virtual Booth

Digital Content

Ambrisentan (med-200028/m)

GDUFA

DMF Review : Complete

Rev. Date : 2014-12-18

Pay. Date : 2014-11-19

DMF Number : 28781

Submission : 2014-11-18

Status : Active

Type : II

02

Watson Pharma Private Ltd

Ireland

DDL Conference

Not Confirmed

03

Cipla Ltd

India

DDL Conference

Not Confirmed

04

Jiangsu Joyglory Pharmaceutical Co L...

China

DDL Conference

Not Confirmed

05

Megafine Pharma P Ltd

India

DDL Conference

Not Confirmed

06

Msn Laboratories Private Ltd

India

DDL Conference

Not Confirmed

07

Sun Pharmaceutical Industries Ltd

India

DDL Conference

Not Confirmed

08

Tianjin Weijie Pharmaceutical Co Ltd

China

DDL Conference

Not Confirmed

09

Tianish Laboratories Private Ltd

U.S.A

DDL Conference

Not Confirmed

10

Zhejiang Huahai Pharmaceutical Co Lt...

China

DDL Conference

Not Confirmed

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

JDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

EU WC

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

KDMF

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

NDC API

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Suppliers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

API Reference Price

[{"dataSource":"API Export","activeIngredients":"AMBRISENTAN","year":"2021","qtr":"Q1","strtotime":1614364200,"product":"AMBRISENTAN - BULK DRUG","address":"B 501 GREAT EASTERN SUMMIT SECTOR15 PLOT NO.66 C B D BELAPUR","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TUTEUR S.A.C.I.F.I.A.","customerCountry":"ARGENTINA","quantity":"0.40","actualQuantity":"0.4","unit":"KGS","unitRateFc":"50000","totalValueFC":"19778.4","currency":"USD","unitRateINR":3600000,"date":"27-Feb-2021","totalValueINR":"1440000","totalValueInUsd":"19778.4","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8994157","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"B 501 GREAT EASTERN SUMMIT SECTOR15 PLOT NO.66 C B D BELAPUR, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1625682600,"product":"OTHER ORGANICS COMPOUND-AMBRISENTAN-BATC H NO. MBM2105001","address":"SETHNA BUILDING, 4TH FLR,55, MAHARSHI KARVE ROAD, MARINE","city":"LINES, MUMBAI ,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"CANONPHARMA PRODUCTION","customerCountry":"RUSSIA","quantity":"0.10","actualQuantity":"0.1","unit":"KGS","unitRateFc":"45602.3","totalValueFC":"4408.7","currency":"USD","unitRateINR":3285642.8999999994,"date":"08-Jul-2021","totalValueINR":"328564.29","totalValueInUsd":"4408.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2975390","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"SETHNA BUILDING, 4TH FLR,55, MAHARSHI KARVE ROAD, MARINE, LINES, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1627929000,"product":"AMBRISENTAN (TAX INVOICE NO:1900215472 D ATE:30.07.2021","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"TOKYO - NARITA","customer":"CBC GROUP","customerCountry":"JAPAN","quantity":"0.97","actualQuantity":"0.97","unit":"KGS","unitRateFc":"50898.8","totalValueFC":"47962.2","currency":"USD","unitRateINR":3667254.6391752576,"date":"03-Aug-2021","totalValueINR":"3557237","totalValueInUsd":"47962.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"3590612","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q3","strtotime":1630434600,"product":"AMBRISENTAN - BULK DRUG **LUT ARN NO. A","address":"B 501 GREAT EASTERN SUMMIT SECTOR15 PLOT NO.66 C B D BELAPUR","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"BAGO GROUP","customerCountry":"ARGENTINA","quantity":"0.46","actualQuantity":"0.46","unit":"KGS","unitRateFc":"57000","totalValueFC":"25925.7","currency":"USD","unitRateINR":4145652.1739130435,"date":"01-Sep-2021","totalValueINR":"1907000","totalValueInUsd":"25925.7","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"4272717","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"B 501 GREAT EASTERN SUMMIT SECTOR15 PLOT NO.66 C B D BELAPUR, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2021","qtr":"Q4","strtotime":1637173800,"product":"AMBRISENTAN (TAX INVOICE NO:1900215916 D","address":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR","city":"HYDERABAD, A.P.","supplier":"MSN LABORATORIES","supplierCountry":"INDIA","foreign_port":"OSAKA","customer":"SAWAI PHARMACEUTICAL CO., LTD.","customerCountry":"JAPAN","quantity":"0.02","actualQuantity":"0.02","unit":"KGS","unitRateFc":"50000","totalValueFC":"886.2","currency":"USD","unitRateINR":3300000,"date":"18-Nov-2021","totalValueINR":"66000","totalValueInUsd":"886.2","indian_port":"HYDERABAD AIR","hs_no":"29339990","bill_no":"6098931","productDescription":"API","marketType":"REGULATED MARKET","country":"JAPAN","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"8-3-167\/D\/16, KALYAN NAGAR - I,VENGAL RAO NAGAR, HYDERABAD, A.P.","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q1","strtotime":1646591400,"product":"AMBRISENTAN - BULK DRUG","address":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,","city":"NAVI MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"FINADIET S.A.","customerCountry":"ARGENTINA","quantity":"1.50","actualQuantity":"1.5","unit":"KGS","unitRateFc":"57000","totalValueFC":"84073","currency":"USD","unitRateINR":4272000,"date":"07-Mar-2022","totalValueINR":"6408000","totalValueInUsd":"84073","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"8755624","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q2","strtotime":1655058600,"product":"AMBRISENTAN","address":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,","city":"NAVI MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TUTEUR S.A.C.I.F.I.A.","customerCountry":"ARGENTINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"60000","totalValueFC":"17714.5","currency":"USD","unitRateINR":4606666.666666667,"date":"13-Jun-2022","totalValueINR":"1382000","totalValueInUsd":"17714.5","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"2092760","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"1701,17TH FL KESAR SOLITAIRE PLOT NO5, SECTOR 19 ,SANPADA,, NAVI MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1663785000,"product":"AMBRISENTAN R-ENANTIOMER (QTY: 70 GMS, P","address":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,","city":"TURKAPALLY-V SHAMIRPET HYDERABAD,TE","supplier":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACIPEIAL CONVENT","customerCountry":"UNITED STATES","quantity":"0.07","actualQuantity":"0.07","unit":"KGS","unitRateFc":"78014.3","totalValueFC":"5365.5","currency":"USD","unitRateINR":6142857.1428571427,"date":"22-Sep-2022","totalValueINR":"430000","totalValueInUsd":"5365.5","indian_port":"HYDERABAD AIR","hs_no":"29335990","bill_no":"4365119","productDescription":"API","marketType":"REGULATED MARKET","country":"UNITED STATES","selfForZScoreResived":"Pharma Grade","supplierPort":"HYDERABAD AIR","supplierAddress":"P.NO. D6 & D8, SY.NO. 234\/2,234\/3, ,235\/2 & 542\/2, IKP KNOWLEDGE PARK,, TURKAPALLY-V SHAMIRPET HYDERABAD,TE","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2022","qtr":"Q3","strtotime":1664217000,"product":"AMBRISENTAN USDMF - BATCH NO: HDP220107","address":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER","city":"PAREL MUMBAI MAHARASHTRA,MAHARASHTR","supplier":"CIPLA","supplierCountry":"INDIA","foreign_port":"SHANGHAI - PU DONG","customer":"GUANGDONG ZESHENG PHAR.CO.,LTD","customerCountry":"CHINA","quantity":"0.30","actualQuantity":"0.3","unit":"KGS","unitRateFc":"45000","totalValueFC":"13239.2","currency":"USD","unitRateINR":3536666.666666667,"date":"27-Sep-2022","totalValueINR":"1061000","totalValueInUsd":"13239.2","indian_port":"BOMBAY AIR","hs_no":"29335990","bill_no":"4463509","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"CIPLA HOUSE, PENINSULA BUSINESS,PA RK,GANPATRAO KADAM MARG,LOWER, PAREL MUMBAI MAHARASHTRA,MAHARASHTR","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1692901800,"product":"AMBRISENTAN.","address":"1706 17TH FL KESAR SOLITAIREPLOT NO 5 SEC 19 SANPADA NAVI","city":"MUMBAI","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"Z TO ORDER AND NA","customerCountry":"ARGENTINA","quantity":"0.34","actualQuantity":"0.34","unit":"KGS","unitRateFc":"60000","totalValueFC":"20192.2","currency":"USD","unitRateINR":4919551.5352941174,"date":"25-Aug-2023","totalValueINR":"1672647.522","totalValueInUsd":"20192.2","indian_port":"BOMBAY AIR","hs_no":"29420090","bill_no":"0","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"BOMBAY AIR","supplierAddress":"1706 17TH FL KESAR SOLITAIREPLOT NO 5 SEC 19 SANPADA NAVI, MUMBAI","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q3","strtotime":1695753000,"product":"PHARMACEUTICAL RAW MATERIALS AMBRISENTAN","address":"1706,17TH FL KESAR SOLITAIRE PLOT","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"TO ORDER","customerCountry":"ARGENTINA","quantity":"0.23","actualQuantity":"0.23","unit":"KGS","unitRateFc":"65000","totalValueFC":"14709.4","currency":"USD","unitRateINR":5308695.6521739131,"date":"27-Sep-2023","totalValueINR":"1221000","totalValueInUsd":"14709.4","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"4216959","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1706,17TH FL KESAR SOLITAIRE PLOT, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2023","qtr":"Q4","strtotime":1703615400,"product":"ACTIVE PHARMACEUTICAL INGREDIENTS - OTHER ORGANIC COMPOUNDS -AMBRISENTAN","address":"SETHNA BUILDING, 4TH FLR,","city":"LINES, MUMBAI ,MAHARASHTRA","supplier":"MEGAFINE PHARMA (P) LIMITED","supplierCountry":"INDIA","foreign_port":"MOSCOW","customer":"TO THE ORDER OF","customerCountry":"RUSSIA","quantity":"0.60","actualQuantity":"600","unit":"GMS","unitRateFc":"29","totalValueFC":"17226.6","currency":"USD","unitRateINR":2390,"date":"27-Dec-2023","totalValueINR":"1434000","totalValueInUsd":"17226.6","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"6337422","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"RUSSIA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"SETHNA BUILDING, 4TH FLR,, LINES, MUMBAI ,MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1725561000,"product":"AMBRISENTAN","address":"1706,17TH FL KESAR SOLITAIRE PLOT","city":"NAVI MUMBAI, MAHARASHTRA","supplier":"ENALTEC LABS PRIVATE LIMITED","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES","customer":"TO ORDER","customerCountry":"ARGENTINA","quantity":"0.90","actualQuantity":"0.9","unit":"KGS","unitRateFc":"60000","totalValueFC":"53425.2","currency":"USD","unitRateINR":4974555.555555555,"date":"06-Sep-2024","totalValueINR":"4477100","totalValueInUsd":"53425.2","indian_port":"Bombay Air","hs_no":"29420090","bill_no":"3824611","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Bombay Air","supplierAddress":"1706,17TH FL KESAR SOLITAIRE PLOT, NAVI MUMBAI, MAHARASHTRA","customerAddress":""},{"dataSource":"API Export","activeIngredients":"","year":"2024","qtr":"Q3","strtotime":1726857000,"product":"AMBRISENTAN","address":"RAGHAVA PRIDE,8-2-603\/1\/27,28,,RD","city":"BANJARA HILLS HYDERABAD,TELANGANA","supplier":"RAGHAVA LIFE SCIENCES","supplierCountry":"INDIA","foreign_port":"BUENOS AIRES, BA","customer":"LABORATORIES CASASCO S.A.I.C","customerCountry":"ARGENTINA","quantity":"0.15","actualQuantity":"150","unit":"GMS","unitRateFc":"60","totalValueFC":"8903.2","currency":"USD","unitRateINR":4974,"date":"21-Sep-2024","totalValueINR":"746100","totalValueInUsd":"8903.2","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"4216086","productDescription":"API","marketType":"LESS REGULATED MARKET","country":"ARGENTINA","selfForZScoreResived":"Pharma Grade","supplierPort":"Hyderabad Air","supplierAddress":"RAGHAVA PRIDE,8-2-603\/1\/27,28,,RD, BANJARA HILLS HYDERABAD,TELANGANA","customerAddress":""},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 1 X 0.4 GMS, VALUE USD: 23.81)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0004","unit":"KGS","unitRateFc":"59525","totalValueFC":"29.2","currency":"USD","unitRateINR":"6049150","date":"21-Feb-2024","totalValueINR":"2419.66","totalValueInUsd":"29.2","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 1 X 0.5 GMS, VALUE USD: 26.51)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0005","unit":"KGS","unitRateFc":"53020","totalValueFC":"32.5","currency":"USD","unitRateINR":"5388100","date":"21-Feb-2024","totalValueINR":"2694.05","totalValueInUsd":"32.5","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"},{"dataSource":"API Import","activeIngredients":"","year":"2024","qtr":"Q1","strtotime":1708453800,"product":"AMBRISENTAN (QTY : 2 X 0.2 GMS, VALUE USD: 18.41\/EACH)(FOC)","address":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,","city":"TURKAPALLY(V),SHAMEERPET, HYDERABAD","supplier":"USP","supplierCountry":"CHINA","foreign_port":"WASHINGTON, DULLES I","customer":"UNITED STATES PHARMACOPEIA - INDIA PRIVATE LIMITED","customerCountry":"INDIA","quantity":"0.00","actualQuantity":"0.0004","unit":"KGS","unitRateFc":"92050","totalValueFC":"45.1","currency":"USD","unitRateINR":"9354475","date":"21-Feb-2024","totalValueINR":"3741.79","totalValueInUsd":"45.1","indian_port":"Hyderabad Air","hs_no":"29335990","bill_no":"2235120","productDescription":"API","marketType":"REGULATED MARKET","country":"CHINA","selfForZScoreResived":"Pharma Grade","supplierPort":"WASHINGTON, DULLES I","supplierAddress":"7135 ENGLISH MUFFIN WAY FREDERICK,MD 21704 USA Frederick, , United States United States","customerAddress":"P.NO. D6 D8, SY.NO. 234\/2,234\/3,"}]

Number of Transactions

Total Quantity (KGS)

Total Value (USD)

Quantity (KGS) & Unit rate (USD/KGS) over time

API Imports and Exports

Importing Country	Total Quantity (KGS)	Average Price (USD/KGS)	Number of Transactions

Upgrade, download data, analyse, strategize, subscribe with us contact

Drugs in Development

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

INTERMEDIATES SUPPLIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDA Orange Book

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Europe

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Canada

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Australia

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

South Africa

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Listed Dossiers

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Related Excipient Companies

Upload your portfolio for free, ask us

Excipients by Applications

Click here to find the perfect excipient manufacturers by their capabilities

Fillers, Diluents & Binders

Coating Systems & Additives

Direct Compression

Disintegrants & Superdisintegrants

Lubricants & Glidants

Co-Processed Excipients

Granulation

Thickeners and Stabilizers

Controlled & Modified Release

Film Formers & Plasticizers

Parenteral

Taste Masking

Coloring Agents

Topical

Rheology Modifiers

Emulsifying Agents

Chewable & Orodispersible Aids

API Stability Enhancers

Solubilizers

Digital Content

Create Content with PharmaCompass, ask us

DATA COMPILATION #PharmaFlow

NEWS #PharmaBuzz

Global Sales Information

Do you need Business Intel? Ask us

US Medicaid Prescriptions

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Finished Drug Prices

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Annual Reports

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Market Place

Do you need sourcing support? Ask us

APIs

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

FDF DOSSIERS

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Patents & EXCLUSIVITIES

Check the patents & exclusivity for this product

US Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

Health Canada Patents

FULL SCREEN VIEW Click here to open all results in a new tab [this preview display 10 results]

ABOUT THIS PAGE

Market Place

Home

Post Enquiry

Market Place

Find Ambrisentan manufacturers, exporters & distributors on PharmaCompass

ACCESS ALL DATA

Browse all information

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

22 API Suppliers

10 USDMF

2 JDMF

7 EU WC

1 KDMF

6 NDC API

12 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

3 Drugs in Development

INTERMEDIATES

4 Intermediates Suppliers

FINISHED DOSAGE FORMULATIONS

102 FDF Dossiers

20 FDA Orange Book

32 Europe

8 Canada

32 Australia

4 South Africa

6 Listed Dossiers

RELATED EXCIPIENT COMPANIES

1 SPI Pharma

2 DKSH

3 Faran Shimi Pharmaceutical

9 Gangwal Healthcare

3 Nanjing Well Pharmaceutical

1 Aeon Procare

4 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

1 BASF

5 Corel Pharma Chem

5 DFE Pharma

6 Gangwal Chemicals

3 Ideal Cures Pvt Ltd

1 Ingredion Pharma Solutions

20 Kerry

9 Microlex e.U

1 Novo Excipients

1 Pharmatrans-Sanaq

3 Pluviaendo

3 Prachin Chemical

10 Roquette

3 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

11 Sigachi Industries

3 Vasa Pharmachem

EXCIPIENTS BY APPLICATIONS

41 Fillers, Diluents & Binders

20 Coating Systems & Additives

19 Direct Compression

15 Disintegrants & Superdisintegrants

13 Lubricants & Glidants

11 Co-Processed Excipients

10 Granulation

10 Thickeners and Stabilizers

9 Controlled & Modified Release

5 Film Formers & Plasticizers

4 Parenteral

3 Taste Masking

2 Coloring Agents

2 Topical

2 Rheology Modifiers

2 Emulsifying Agents

2 Chewable & Orodispersible Aids

1 API Stability Enhancers

1 Solubilizers

DIGITAL CONTENT

1 DATA COMPILATION #PharmaFlow

14 NEWS #PharmaBuzz

GLOBAL SALES INFORMATION

2 US Medicaid Prescriptions

26 Finished Drug Prices

10 Annual Reports

MARKET PLACE

6 APIs

5 FDF Dossiers